Raphael Teipel
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- CAR-T cell therapy research
Papers in
- Hematology 29
- Multiple Myeloma Research and Treatments 16
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 7
- Oncology 17
- CAR-T cell therapy research 13
- Co-authors
- Martin Bornhäuser (17 shared papers)Frank Kroschinsky (9 shared papers)Johannes Schetelig (11 shared papers)Malte v. Bonin (9 shared papers)Christian Thiede (4 shared papers)Michael Krämer (6 shared papers)Uta Oelschlägel (5 shared papers)Gerhard Ehninger (6 shared papers)
- Journals
- Blood (6 papers)Bone Marrow Transplantation (4 papers)Leukemia (3 papers)Transplantation and Cellular Therapy (3 papers)Transfusion (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Raphael Teipel
39 papers receiving 474 citations
Raphael Teipel's Hit Papers
Peers
Comparison fields: 5 of 41
- Hematology 299
- Oncology 160
- Genetics 64
- Transplantation 9
- Immunology 55
Countries citing papers authored by Raphael Teipel
This map shows the geographic impact of Raphael Teipel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Teipel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Teipel more than expected).
Fields of papers citing papers by Raphael Teipel
This network shows the impact of papers produced by Raphael Teipel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Teipel. The network helps show where Raphael Teipel may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Teipel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Real-world analysis of teclistamab in 123 RRMM patients from Germany Hit paper breakdown → | 2024 | 68 |
| 2 | 2022 | 45 | |
| 3 | 2022 | 44 | |
| 4 | 2024 | 35 | |
| 5 | 2015 | 34 | |
| 6 | 2018 | 32 | |
| 7 | 2021 | 31 | |
| 8 | 2016 | 22 | |
| 9 | 2025 | 20 | |
| 10 | 2020 | 17 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 11 | |
| 13 | 2025 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2025 | 8 | |
| 17 | 2019 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2016 | 5 | |
| 20 | 2022 | 4 |
About Raphael Teipel
Raphael Teipel is a scholar working on Hematology, Oncology, Genetics, Immunology and Public Health, Environmental and Occupational Health, having authored 44 papers that have together received 479 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), CAR-T cell therapy research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (4 papers), Protein Degradation and Inhibitors (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (299 citations), Oncology (160 citations), Genetics (64 citations), Transplantation (9 citations) and Immunology (55 citations). Raphael Teipel has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Martin Bornhäuser, Frank Kroschinsky, Johannes Schetelig, Malte v. Bonin, Christian Thiede, Michael Krämer, Uta Oelschlägel, Gerhard Ehninger, Helmuth Schmidt and Jan Moritz Middeke. Their work appears in journals such as Blood, Bone Marrow Transplantation, Leukemia, Transplantation and Cellular Therapy and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.